SYNAGEVA BIOPHARMA CORP's ticker is and the CUSIP is 87159A953. A total of 1 filers reported holding SYNAGEVA BIOPHARMA CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $897,000 | +184.8% | 9,200 | +170.6% | 0.00% | – |
| Q4 2014 | $315,000 | -23.7% | 3,400 | -43.3% | 0.00% | – |
| Q3 2014 | $413,000 | -84.9% | 6,000 | -77.0% | 0.00% | -100.0% |
| Q2 2014 | $2,735,000 | -20.8% | 26,100 | -37.3% | 0.00% | -25.0% |
| Q1 2014 | $3,452,000 | +3693.4% | 41,600 | +2871.4% | 0.00% | – |
| Q4 2013 | $91,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Citadel Advisors | 3,400 | $315,000 | 0.00% |